Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Light Chain Nephropathy”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableStudy completedNCT06549634
What this trial is testing

Biomarkers of AKI in Patients Receiving Daratumumab

Who this might be right for
Acute Kidney InjuryMultiple MyelomaLight Chain Nephropathy
Brigham and Women's Hospital 20
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Not applicableStudy completedNCT00700531
What this trial is testing

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Who this might be right for
Multiple MyelomaCast NephropathyKidney Failure
University Hospital Birmingham 90
Not applicableStudy completedNCT01758042
What this trial is testing

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Who this might be right for
Chronic Kidney DiseaseAcute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)+14 more
Massachusetts General Hospital 10
Not applicableStudy completedNCT04747067
What this trial is testing

To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.

Who this might be right for
End Stage Renal DiseaseHemodiafiltrationHemodialysis
Ain Shams University 25
Not applicableStudy completedNCT02358980
What this trial is testing

Kidney Therapy for Free Light Chain Removal in Patients With Multiple Myeloma & Cast Nephropathy

Who this might be right for
Multiple MyelomaCast NephropathyAcute Kidney Injury
Azienda USL Reggio Emilia - IRCCS 5
Not applicableLooking for participantsNCT06483139
What this trial is testing

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Who this might be right for
Multiple MyelomaLight Chain NephropathyAcute Kidney Injury
Brigham and Women's Hospital 450
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Large-scale testing (Phase 3)Study completedNCT01208818
What this trial is testing

Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy

Who this might be right for
Chronic Renal Failure With Uremic Nephropathy
Assistance Publique - Hôpitaux de Paris 284
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT01531751
What this trial is testing

High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease

Who this might be right for
Primary Amyloidosis of Light Chain Type
Fondazione IRCCS Policlinico San Matteo di Pavia
Testing effectiveness (Phase 2)Study completedNCT02424851
What this trial is testing

Optimising Renal Outcome in Myeloma Renal Failure

Who this might be right for
Multiple MyelomaChronic Kidney Disease
Oxford University Hospitals NHS Trust 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT07085728
What this trial is testing

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

Who this might be right for
Myeloma Multiple
Eastern Cooperative Oncology Group 74
Testing effectiveness (Phase 2)Study completedNCT00006251
What this trial is testing

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more
Fred Hutchinson Cancer Center 21
Not applicableStudy completedNCT00120263
What this trial is testing

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

Who this might be right for
Multiple MyelomaAcute Renal Failure
London Health Sciences Centre 92
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42